{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:42:28Z","timestamp":1791517348905,"version":"4.3.4"},"reference-count":44,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"\n Importance<\/jats:title>\n Central centrifugal cicatricial alopecia (CCCA) is a scarring alopecia predominantly affecting Black female individuals. Current conventional treatments target inflammation but not the underlying fibrotic processes, often leading to permanent hair loss.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To investigate the associations of low-dose oral metformin, an antidiabetic medication with antifibrotic properties, with clinical symptoms and scalp gene expression patterns in patients with CCCA.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This retrospective clinical case series and transcriptomic analysis included patients treated at a single tertiary academic medical center between January 2023 and March 2024. All patients had biopsy-confirmed CCCA refractory to standard treatments. Transcriptomic analysis was performed on patients with previously banked, paired scalp biopsies before and after treatment with adjuvant metformin for at least 6 weeks.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Extended-release metformin, 500 mg, once daily was added to participants\u2019 baseline CCCA treatment regimens.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Clinical assessments included pruritus, inflammation, scalp resistance, and hair regrowth. Gene expression profiling via bulk RNA sequencing analysis evaluated differential gene expression and pathway enrichment.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 12 Black female participants were included in the study, and transcriptomic analysis was performed in 4 participants. After at least 6 months of metformin treatment, 9 participants experienced improvement in disease, including scalp pain, inflammation, and\/or pruritus, and 6 demonstrated clinical evidence of hair regrowth. The addition of metformin led to reversal of many prominent gene pathways previously identified in CCCA. Transcriptomic analysis revealed upregulation of pathways and genes (keratin-associated proteins [KRTAPs]) involved in keratinization, epidermis development, and the hair cycle (absolute log\n 2<\/jats:sub>\n -fold change &amp;gt; 4), with concomitant downregulation of fibrosis-related pathways and genes (eg,\n MMP7<\/jats:italic>\n ,\n COL6A1<\/jats:italic>\n ) (fold change &amp;gt;1.5; all false discovery rate &amp;lt;.05). Gene set analysis showed reduced expression of helper T cell 17 and epithelial-mesenchymal transition pathways and elevated adenosine monophosphate kinase signaling and KRTAPs after metformin treatment.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this case series of patients with treatment-refractory CCCA, low-dose oral metformin was associated with symptomatic improvement and dual modulation of gene expression, stimulating hair growth pathways while suppressing fibrosis and inflammation markers. These findings provide a rationale for future clinical trials studying metformin as a targeted therapy for CCCA and other cicatricial alopecias.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamadermatol.2024.3062","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T11:11:47Z","timestamp":1725448307000},"page":"1211","source":"Crossref","is-referenced-by-count":25,"title":["Low-Dose Metformin and Profibrotic Signature in Central Centrifugal Cicatricial Alopecia"],"prefix":"10.1001","volume":"160","author":[{"given":"Aaron","family":"Bao","sequence":"first","affiliation":[{"name":"Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aasheen","family":"Qadri","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Gadre","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Georgetown University School of Medicine, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Will","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rexford","family":"Ahima","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, The Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey A.","family":"Bordone","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Aguh","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"doi240035r1","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.jaad.2022.08.031","article-title":"Type 2 diabetes mellitus and central centrifugal cicatricial alopecia severity.","volume":"87","author":"Ali","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"doi240035r2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1529-8019.2008.00209.x","article-title":"Central centrifugal cicatricial alopecia.","volume":"21","author":"Whiting","year":"2008","journal-title":"Dermatol Ther"},{"issue":"5","key":"doi240035r3","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jaad.2018.05.1257","article-title":"Fibroproliferative genes are preferentially expressed in central centrifugal cicatricial alopecia.","volume":"79","author":"Aguh","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"doi240035r4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2147\/CCID.S284435","article-title":"Topical treatment for scarring and non-scarring alopecia: an overview of the current evidence.","volume":"14","author":"Cardoso","year":"2021","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"2","key":"doi240035r5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis.","volume":"214","author":"Wynn","year":"2008","journal-title":"J Pathol"},{"issue":"9","key":"doi240035r6","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin.","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"doi240035r7","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6673525","article-title":"Metformin and fibrosis: a review of existing evidence and mechanisms.","volume":"2021","author":"Wu","year":"2021","journal-title":"J Diabetes Res"},{"issue":"4","key":"doi240035r8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/SAP.0000000000002574","article-title":"Metformin inhibits transforming growth factor \u00df-induced fibrogenic response of human dermal fibroblasts and suppresses fibrosis in keloid spheroids.","volume":"86","author":"Jeon","year":"2021","journal-title":"Ann Plast Surg"},{"issue":"1","key":"doi240035r9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12967-021-02860-z","article-title":"Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts.","volume":"19","author":"Moon","year":"2021","journal-title":"J Transl Med"},{"key":"doi240035r10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jdin.2023.09.005","article-title":"Increased IL-1\u00df in stratum corneum as a marker of inflammation among central centrifugal cicatricial alopecia patients with pruritus: an observational study.","volume":"13","author":"Gadre","year":"2023","journal-title":"JAAD Int"},{"issue":"105844","key":"doi240035r11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105844","article-title":"Activated AMPK by metformin protects against fibroblast proliferation during pulmonary fibrosis by suppressing FOXM1.","volume":"173","author":"Gu","year":"2021","journal-title":"Pharmacol Res"},{"issue":"2","key":"doi240035r12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jdcr.2019.12.008","article-title":"Hair regrowth in 2 patients with recalcitrant central centrifugal cicatricial alopecia after use of topical metformin.","volume":"6","author":"Araoye","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"2","key":"doi240035r13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1900\/RDS.2004.1.89","article-title":"\u201cLow dose\u201d metformin improves hyperglycemia better than acarbose in type 2 diabetics.","volume":"1","author":"Yajima","year":"2004","journal-title":"Rev Diabet Stud"},{"issue":"1","key":"doi240035r14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41392-022-01040-9","article-title":"Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects.","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"doi240035r15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3904\/kjim.2021.363","article-title":"Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease.","volume":"37","author":"Kim","year":"2022","journal-title":"Korean J Intern Med"},{"key":"doi240035r16","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8491742","article-title":"Metformin and diammonium glycyrrhizinate enteric-coated capsule versus metformin alone versus diammonium glycyrrhizinate enteric-coated capsule alone in patients with nonalcoholic fatty liver disease and type 2 diabetes mellitus.","author":"Zhang","journal-title":"Gastroenterol Res Pract"},{"issue":"1","key":"doi240035r17","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1038\/s41467-019-10839-0","article-title":"Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis.","volume":"10","author":"Kheirollahi","year":"2019","journal-title":"Nat Commun"},{"issue":"8","key":"doi240035r18","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s00403-023-02630-5","article-title":"Clinical factors and hair care practices influencing outcomes in central centrifugal cicatricial alopecia.","volume":"315","author":"Onamusi","year":"2023","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"doi240035r19","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgac111","article-title":"Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways.","volume":"1","author":"Wang","year":"2022","journal-title":"Proc Natl Acad Sci U S A Nexus"},{"issue":"3","key":"doi240035r20","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jaad.2021.02.036","article-title":"Association of type 2 diabetes with central centrifugal cicatricial alopecia: a follow-up study.","volume":"86","author":"Roche","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"doi240035r21","first-page":"2393","article-title":"Metformin mitigates autoimmune insulitis by inhibiting Th1 and Th17 responses while promoting Treg production.","volume":"11","author":"Duan","year":"2019","journal-title":"Am J Transl Res"},{"issue":"102342","key":"doi240035r22","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102342","article-title":"Metformin modulates mitochondrial function and mitophagy in peripheral blood mononuclear cells from type 2 diabetic patients.","volume":"53","author":"de Mara\u00f1\u00f3n","year":"2022","journal-title":"Redox Biol"},{"issue":"6","key":"doi240035r23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/ijd.15885","article-title":"The role of interleukin-17 (IL-17) in the pathogenesis of discoid lupus erythematosus and lichen planopilaris: is immunohistochemistry for IL-17 a promising way to differentiate these entities?","volume":"61","author":"Shahidi Dadras","year":"2022","journal-title":"Int J Dermatol"},{"issue":"11","key":"doi240035r24","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1016\/j.jid.2017.05.033","article-title":"Hidradenitis suppurativa is characterized by dysregulation of the Th17:Treg cell axis, which is corrected by anti-TNF therapy.","volume":"137","author":"Moran","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"4","key":"doi240035r25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1515\/rjim-2017-0027","article-title":"IL-17 and Th17 cells in systemic sclerosis: a comprehensive review.","volume":"55","author":"Balanescu","year":"2017","journal-title":"Rom J Intern Med"},{"issue":"8","key":"doi240035r26","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.3390\/ijms24086969","article-title":"Metformin treatment of hidradenitis suppurativa: effect on metabolic parameters, inflammation, cardiovascular risk biomarkers, and immune mediators.","volume":"24","author":"Hambly","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"doi240035r27","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/bjd\/ljad305","article-title":"Metformin has anti-inflammatory effects and induces immunometabolic reprogramming via multiple mechanisms in hidradenitis suppurativa.","volume":"189","author":"Petrasca","year":"2023","journal-title":"Br J Dermatol"},{"issue":"1","key":"doi240035r28","doi-asserted-by":"publisher","first-page":"00074","DOI":"10.1183\/23120541.00074-2016","article-title":"MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis.","volume":"3","author":"Bauer","year":"2017","journal-title":"ERJ Open Res"},{"issue":"1","key":"doi240035r29","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1038\/s41598-021-82315-z","article-title":"Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease.","volume":"11","author":"Irvine","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"doi240035r30","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/exd.14524","article-title":"Gene expression profiling suggests severe, extensive central centrifugal cicatricial alopecia may be both clinically and biologically distinct from limited disease subtypes.","volume":"31","author":"Jamerson","year":"2022","journal-title":"Exp Dermatol"},{"key":"doi240035r31","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.3389\/fphys.2018.01129","article-title":"Extracellular collagen VI has prosurvival and autophagy instructive properties in mouse fibroblasts.","volume":"9","author":"Castagnaro","year":"2018","journal-title":"Front Physiol"},{"issue":"1","key":"doi240035r32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/pde.14883","article-title":"Keratosis pilaris in collagen type VI-related disorders.","volume":"39","author":"Ritter","year":"2022","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"doi240035r33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/pde.14862","article-title":"Atypical keratosis pilaris-like lesions in a patient with Bethlem myopathy.","volume":"39","author":"Lee","year":"2022","journal-title":"Pediatr Dermatol"},{"issue":"7","key":"doi240035r34","doi-asserted-by":"publisher","first-page":"6678","DOI":"10.3390\/ijms24076678","article-title":"Alopecia in patients with collagen VI-related myopathies: a novel\/unrecognized scalp phenotype.","volume":"24","author":"Starace","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"10","key":"doi240035r35","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1038\/jid.2015.187","article-title":"Lack of collagen VI promotes wound-induced hair growth.","volume":"135","author":"Chen","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"12","key":"doi240035r36","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni732","article-title":"Dermcidin: a novel human antibiotic peptide secreted by sweat glands.","volume":"2","author":"Schittek","year":"2001","journal-title":"Nat Immunol"},{"key":"doi240035r37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.imlet.2022.09.008","article-title":"Dermcidin-derived polypeptides: DCD(86-103) induced inflammatory reaction in the skin by activation of mast cells via ST2.","volume":"251-252","author":"Che","year":"2022","journal-title":"Immunol Lett"},{"issue":"10","key":"doi240035r38","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.ad.2015.03.021","article-title":"Mast cells and scarring alopecia: is there a clear pathophysiological relationship?","volume":"106","author":"Almodovar-Real","year":"2015","journal-title":"Actas Dermosifiliogr"},{"key":"doi240035r39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jdin.2023.11.008","article-title":"Quantification of mast cells in central centrifugal cicatricial alopecia.","volume":"15","author":"Look-Why","year":"2023","journal-title":"JAAD Int"},{"issue":"1","key":"doi240035r40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00335-020-09854-0","article-title":"Alopecia in Harlequin mutant mice is associated with reduced AIF protein levels and expression of retroviral elements.","volume":"32","author":"Hintze","year":"2021","journal-title":"Mamm Genome"},{"issue":"6","key":"doi240035r41","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1111\/bjd.13399","article-title":"Similar response patterns to topical minoxidil foam 5% in frontal and vertex scalp of men with androgenetic alopecia: a microarray analysis.","volume":"172","author":"Mirmirani","year":"2015","journal-title":"Br J Dermatol"},{"issue":"102810","key":"doi240035r42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102810","article-title":"Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to hair keratinization and is involved in hair loss.","volume":"57","author":"Oka","year":"2020","journal-title":"EBioMedicine"},{"issue":"9","key":"doi240035r43","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1056\/NEJMoa1816614","article-title":"Variant PADI3 in central centrifugal cicatricial alopecia.","volume":"380","author":"Malki","year":"2019","journal-title":"N Engl J Med"},{"issue":"19","key":"doi240035r44","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1001\/jama.2019.3805","article-title":"Metformin in 2019.","volume":"321","author":"Flory","year":"2019","journal-title":"JAMA"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2822779\/jamadermatology_bao_2024_oi_240035_1731688984.06604.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T11:02:51Z","timestamp":1732100571000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2822779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2024.3062","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,1]]}}}